METODOLOGÍA PARA LA MEJORA ARQUITECTÓNICA DE REPOSITORIOS UNIVERSITARIOS.

Autor: Fernández-Luna, Adri๠adriafluna@gmail.com, Pérez-Montoro Gutiérrez, Mario² perez-montoro@ub.edu, Guallar Delgado, Javier² jguallar@gmail.com

Publikováno v: Anales de Documentación. 2019, Vol. 22 Issue 2, p1-19. 19p.

Eggshell and egg yolk proteins in fish: hepatic proteins for the next generation: oogenetic, population, and evolutionary implications of endocrine disruption.

Autor: Arukwe, Augustine¹ arukwe@uwindsor.ca, Goksøyr, Anders^2,3 anders@biosense.no

Publikováno v: Comparative Hepatology. 2003, Vol. 2, p4-21. 21p. 6 Diagrams, 3 Graphs.

Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.

Autor: Flume PA; MUSC Health Cystic Fibrosis Center, Medical University of South Carolina, Charleston, SC, USA. Electronic address: flumepa@musc.edu., Biner RF; Quartier Bleu, Lindenhof Hospital, Bern, Switzerland., Downey DG; Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK., Brown C; Department of Pulmonary and Critical Care Medicine, Indiana University School of Medicine, Indianapolis, IN, USA., Jain M; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Fischer R; Pneumologische Praxis München-Pasing, Munich, Germany., De Boeck K; Pediatric Pulmonology, University Hospital of Leuven, Leuven, Belgium., Sawicki GS; Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Chang P; Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Paz-Diaz H; Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Rubin JL; Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Yang Y; Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Hu X; Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Pasta DJ; ICON Clinical Research Inc, North Wales, PA, USA., Millar SJ; ICON Clinical Research Inc, North Wales, PA, USA., Campbell D; Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Wang X; Vertex Pharmaceuticals Incorporated, Boston, MA, USA; US Food and Drug Administration, Silver Spring, MD, USA., Ahluwalia N; Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Owen CA; Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Wainwright CE; Child Health Research Centre, University of Queensland, Brisbane, QLD, Australia.

Publikováno v: The Lancet. Respiratory medicine [Lancet Respir Med] 2021 Jul; Vol. 9 (7), pp. 733-746. Date of Electronic Publication: 2021 Feb 10.

The Effect of Creosote on Vitellogenin Production in Rainbow Trout ( Oncorhynchus mykiss).

Autor: Sherry, J. P., Whyte, J. J., Karrow, N. A., Gamble, A., Boerman, H. J., Bol, N. C., Dixon, D. G., Solomon, K. R.

Publikováno v: Archives of Environmental Contamination & Toxicology; Jan2006, Vol. 50 Issue 1, p65-68, 4p

Airway Inflammation and Infection in Congenital Bilateral Absence of the Vas Deferens.

Autor: Gilljam, Marita, Moltyaner, Yuri, Downey, Gregory P., Devlin, Roslyn, Durie, Peter, Cantin, André M., Zielenski, Julian, Elizabeth Tullis, D.

Publikováno v: American Journal of Respiratory & Critical Care Medicine; 2004, Vol. 169 Issue 2, p1-6, 12p, 4 Charts, 1 Graph